By Professor Glenda Halliday

Journal articles

Sachdev PS; Lee T; Lammel A; Crawford J; Trollor JN; Wright MJ; Brodaty H; Ames D; Martin NG, 2011, 'Cognitive functioning in older twins: The Older Australian Twins Study', Australasian Journal on Ageing, 30, pp. 17 - 23, http://dx.doi.org/10.1111/j.1741-6612.2011.00534.x

Chen-Plotkin A; Martinez-Lage M; Sleiman PMA; Hu W; Greene R; Wood EF; Bing S; Grossman M; Schellenberg GD; Hatanpaa K; Weiner M; White III CL; Brooks WS; Halliday GM; Kril JJ; Gearing M; Beach T; Graff-radford N; Dickson D; Rademakers R; Boeve B; Pickering-Brown SM; Snowden J; Van Swieten JC; Heutink P; Seelaar H; Murrell J; Ghetti B; Spina S; Grafman J; Kaye JA; Woltjer RL; Mesulam M; Bigio EH; Llado A; Miller B; Alzualde A; Moreno FS; Rohrer JD; Mackenzie IRA; Feldman H; Hamilton RL; Cruts M; Engelborghs ; De Deyn PP; Van Broeckhoven C; Bird T; Cairns NJ; Goate A; Frosch MP; Riederer PF; Bogdanovic N; Lee VM; Trojanowski JQ; Van deerlin VM, 2011, 'Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration', Archives of Neurology, 68, pp. 488 - 497

Halliday GM; Stevens C, 2011, 'Glia: Initiators and progressors of pathology in Parkinson's disease', Movement Disorders, 26, pp. 6 - 17, http://dx.doi.org/10.1002/23455

Huang Y; Rowe DB; Halliday , 2011, 'Interaction between a-synuclein and tau genotypes and the progression of Parkinson's disease', Journal of Parkinson's Disease, 1, pp. 271 - 276, http://dx.doi.org/10.3233/JPD-2011-11027

Masters CL; Kril J; Halliday GM; Pamphlett R; Collins S; Hill AF; McLean CA, 2011, 'Overview and recent advances in neuropathology. Part 2: Neurodegeneration', Pathology, 43, pp. 93 - 102, http://dx.doi.org/10.1097/PAT.0b013e3283426eee

Dobson‐Stone C; Luty A; Hallupp M; Coupland K; Brooks W; Panegyres P; Piguet O; Broe GA; Sobow T; Zekanowski C; Halliday G; Schofield P; Kwok J, 2011, 'P1‐285: Sigma non‐opioid intracellular receptor 1 and neurodegeneration: prevalence of mutations and therapeutic implications', Alzheimer's & Dementia, 7, http://dx.doi.org/10.1016/j.jalz.2011.05.566

Kwok J; Luty A; Dobson‐Stone C; Loy C; Brooks W; Karlström H; Halliday G; Schofield P, 2011, 'P1‐287: Positional cloning identifies SIGMAR1 gene as a causative locus for FTLD‐MND in a large Australian pedigree', Alzheimer's & Dementia, 7, http://dx.doi.org/10.1016/j.jalz.2011.05.568

Kril J; Halliday GM, 2011, 'Pathological staging of frontotemporal lobar degeneration', Journal of Molecular Neuroscience, 45, pp. 379 - 383, http://dx.doi.org/10.1007/s12031-011-9528-0

Komadina N; Terpening Z; Huang Y; Halliday GM; Lewis SJG; Naismith S, 2011, 'Utility and limitations of Addenbrooke's cognitive examination-revised for detecting mild cognitive impairment in Parkinson's disease', Dementia and Geriatric Cognitive Disorders, 31, pp. 349 - 357, http://dx.doi.org/10.1159/000328165

Shine JM; Halliday GM; Lewis SJG; Naismith S, 2011, 'Visual misperceptions and hallucinations in Parkinson's disease: Dysfunction of attentional control networks?', Movement Disorders, 26, pp. 2154 - 2159, http://dx.doi.org/10.1002/mds.23896

Sou PW; Delic NC; Halliday GM; Lyons JG, 2010, 'Snail transcription factors in keratinocytes: Enough to make your skin crawl', International Journal of Biochemistry and Cell Biology, 42, pp. 1940 - 1944, http://dx.doi.org/10.1016/j.biocel.2010.08.021

Gabery S; Murphy K; Schultz K; Loy C; McCusker E; Kirik D; Halliday G; Petersen A, 2010, 'CHANGES IN KEY HYPOTHALAMIC NEUROPEPTIDE POPULATIONS IN HUNTINGTON'S DISEASE REVEALED BY NEUROPATHOLOGICAL ANALYSES', JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 81, pp. A7 - A8, http://dx.doi.org/10.1136/jnnp.2010.222570.23

Huang Y; Zheng L; Halliday G; Dobson-Stone C; Wang YY; Tang HD; Kowk J; Chen SD, 2010, '78. Genetic influences of sigma-1 receptor and apolipoprotein E on the severity of Alzheimer’s disease', Journal of Clinical Neuroscience, 17, pp. 1633 - 1633, http://dx.doi.org/10.1016/j.jocn.2010.07.079

Van deerlin VM; Sleiman PMA; Martinez-Lage M; Chen-Plotkin A; Wang LS; Graff-Radford NR; Dickson DW; Rademakers R; Boeve BF; Grossman M; Arnold SE; Mann DMA; Pickering-Brown SM; Seelaar H; Heutink P; Van Swieten JC; Murrell JR; Ghetti B; Spina S; Grafman J; Hodges JR; Spillantini MG; Gilman S; Lieberman AP; Kaye JA; Woltjer RL; Bigio EH; Mesulam M; al-Sarraj S; Troakes C; Rosenberg RN; White III CL; Ferrer I; Llado A; Neumann M; Kretzschmar HA; Hulette CM; Welsh-Bohmer KA; Miller BL; Alzualde A; Lopez de Munain A; McKee AC; Gearing M; Levey AI; Lah JL; Hardy J; Rohrer JD; Lashley T; Mackenzie IRA; Feldman HH; Hamilton RL; Dekosky ST; Van der zee ST; Kumar-Singh S; Van Broeckhoven C; Mayeux R; Vonsattel ; Troncoso JC; Kril JJ; Bird T; Halliday GM; Ince PG; Shaw PA; Kwok JB; Cairns NJ; Morris JC; Mclean ; DeCarli C; Ellis WG; Freeman SH; Frosch MP; Growdon JH; Perl DP; Perl DP; Sano DP; Sano M; Bennett DA; Schneider JA; Beach TG; Reiman EM; Woodruff BK; Cummings J; Vinters HV; Miller ; Chui HC; Alafuzoff I; Hartikainen P; Seilhean D; Galasko D; Masliah E; Cotman E; Tunon MT; Martinez MCC; Munoz DG; Carroll SL; Marson SL; Riederer PF; Bogdanovic N; Schellenberg GD; Hakonarson H; Tronjanowski JQ; Lee VMY, 2010, 'Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions', Nature Genetics, 42, pp. 234 - 239

Mitew S; Kirkcaldie MTK; Halliday GM; Shepherd CE; Vickers JC; Dickson TC, 2010, 'Focal demyelination in Alzheimer's disease and transgenic', ACTA Neuropathologica, 119, pp. 567 - 577

Ma M; Huang Y; Chen S; Halliday GM, 2010, 'Immunohistochemical evidence for macroautophagy in neurons and endothelial cells in Alzheimer's disease', Neuropathology and Applied Neurobiology, 36, pp. 312 - 319

Kim WS; Bhatia S; Elliott DA; Agholme L; Kagedal K; Mccann H; Halliday GM; Barnham K; Garner B, 2010, 'Increased ATP-binding cassette trabsporter A1 expression in Alzheimer's disease hippocampal neurons', Journal of Alzheimer's Disease, 21, pp. 193 - 205

Kagedal K; Kim WS; Appelqvist A; Chan LL; Cheng D; Agholme L; Barnham K; Mccann H; Halliday GM; Garner B, 2010, 'Increased expression of the lysosomal cholesterol transporter NPC1 in Alzheimer's disease', Biochimica et Biophysica ACTA - Molecular and Cell Biology of Lipids, 1801, pp. 831 - 838

Schofield E; Halliday GM; Kwok J; Loy C; Double KL; Hodges JR, 2010, 'Low serum progranulin predicts the presence of mutations: a prospective study', Journal of Alzheimer's Disease, 22, pp. 981 - 984

Obeso J; Rodriguez-oroz M; Goetz CG; Marin C; Kordower J; Rodriguez M; Hirsch E; Farrer M; Schapira A; Halliday GM, 2010, 'Missing pieces in the Parkinson's disease puzzle', Nature Medicine, 16, pp. 653 - 661

Mackenzie IRA; Neumann M; Bigio EH; Cairns NJ; Alafuzoff I; Kril J; Kovacs G; Ghetti B; Halliday GM; Holm IE; Ince PG; Kamphorst W; Revesz T; Rozemuller AJM; Kumar-Singh S; Akiyama H; Baborie A; Spina S; Dickson D; Trojanowski JQ; Mann DMA, 2010, 'Nomenclature and nosology for neurophathologic subtypes of frontotemporal lobar degeneration: an update', ACTA Neuropathologica, 119, pp. 1 - 4

Kågedal K; Kim W; Appelqvist H; Chan S; Cheng D; Hellström L; Barnham K; McCann H; Halliday G; Garner B, 2010, 'P4‐153: Increased Expression of the Lysosomal Cholesterol Transporter NPC1 in Alzheimer's Disease', Alzheimer's & Dementia, 6, http://dx.doi.org/10.1016/j.jalz.2010.08.212

Double KL; Halliday GM; Dunkley PR; Dickson PW; Gerlach M; Riederer P, 2010, 'Pigmentation in the Human Brain and Risk of Parkinson's Disease', Annals of Neurology, 67, pp. 553 - 553

Loy CT; Jillian JK; Trollor JN; Kiernan MC; Kwok J; Vucic O; Halliday GM; Hodges JR, 2010, 'The case of a 48 year-old woman with bizarre and complex delusions', Nature Reviews Neurology, 6, pp. 175 - 179, http://www.nature.com/nrneurol/journal/v6/n3/abs/nrneurol.2010.3.html

Halliday GM; Mccann H, 2010, 'The progression of pathology in Parkinson's disease', Annals of the New York Academy of Sciences, 1184, pp. 188 - 195

Loy C; McCusker E; Kril J; Kwok J; Brooks WS; Mccann H; Isaacs A; Halliday GM, 2010, 'Very early onset frontotemporal dementia with no family history preducts underlying fused in sarcoma pathology', Brain, 133, pp. e158, http://dx.doi.org/10.1093/brain/awq186

Shehadeh J; Double K; Murphy K; Bobrovskaya L; Reyes S; Dunkley P; Dickson P; Halliday G, 2009, 'Differential distribution of tyrosine hydroxylase isoforms in the human brain', PARKINSONISM & RELATED DISORDERS, 15, pp. S164 - S164, http://dx.doi.org/10.1016/S1353-8020(09)70625-X

Halliday GM; Bock VL; Moloney FJ; Lyons JG, 2009, 'SWI/SNF: A chromatin-remodelling complex with a role in carcinogenesis', International Journal of Biochemistry and Cell Biology, 41, pp. 725 - 728, http://dx.doi.org/10.1016/j.biocel.2008.04.026

Moloney FJ; Lyons JG; Bock VL; Huang XX; Bugeja MJ; Halliday GM, 2009, 'Hotspot mutation of Brahma in non-melanoma skin cancer', Journal of Investigative Dermatology, 129, pp. 1012 - 1015, http://dx.doi.org/10.1038/jid.2008.319

Halliday GM; King A; McCann H, 2009, '118. Impact of changes in the consensus diagnostic criteria for dementia with lewy bodies', Journal of Clinical Neuroscience, 16, pp. 466 - 467, http://dx.doi.org/10.1016/j.jocn.2008.07.017

Mehta P; Klein C; Proos A; Manwaring N; Vandebona H; Rowe DB; Halliday GM; Sue CM, 2009, '31. Analysis of PINK1 and PARKIN gene mutations in patients with Parkinson’s disease in the Australian community', Journal of Clinical Neuroscience, 16, pp. 1535 - 1535, http://dx.doi.org/10.1016/j.jocn.2009.07.056

Sachdev PS; Lammel A; Trollor JN; Lee T; Wright MJ; Ames D; Wen W; Martin NG; Brodaty H; Schofield PR; Lammel A; Lux O; Halliday G; Kumfor F; Broe G; Schofield P, 2009, 'A comprehensive neuropsychiatric study of elderly twins: the older australian twin study', Twin research and human genetics, 12, pp. 573 - 582, http://dx.doi.org/10.1375/twin.12.6.573

2009, 'Abstracts of the 110th Meeting of the British Neuropathological Society. January 7-9, 2009. London, United Kingdom.', Neuropathol Appl Neurobiol, 35 Suppl 1, pp. 1 - 38, http://dx.doi.org/10.1111/j.1365-2990.2008.01003.x

Double KL; Rowe DB; Carew-Jones F; Hayes M; Chan DK; Blackie J; Corbett AJ; Joffe R; Fung VS; Morris JG; Riederer P; Gerlach M; Halliday GM, 2009, 'Anti-melanin antibodies are increased in sera in Parkinson`s disease', Experimental Neurology, 217, pp. 297 - 301

Woodhouse A; Shepherd CE; Sokolova A; Carroll V; King AE; Halliday GM; Dickson TC; Vickers J, 2009, 'Cytoskeletal alterations differentiate presenilin-1 and sporadic Alzheimer's disease', ACTA Neuropathologica, 117, pp. 19 - 29

Song YC; Halliday GM; Holton J; Lashley T; Osullivan S; Mccann H; Lees A; Ozawa T; Williams DR; Lockhart PJ; Revesz T, 2009, 'Degeneration in different parkinsonian syndromes relates to astrocyte type and astrocyte protein expression', Journal of Neuropathology and Experimental Neurology, 68, pp. 1073 - 1083

Sutherland GT; Halliday GM; Silburn PA; Mastaglia F; Rowe DB; Boyle R; O Sullivan JD; Ly T; Wilton SD; Mellick GD, 2009, 'Do polymorphisms in the familial parkinsonism genes contribute to risk for sporadic Parkinson`s disease?', Movement Disorders, 24, pp. 833 - 838

Piguet O; Halliday GM; Creasey H; Broe T; Kril J, 2009, 'Frontotemporal dementia and dementia with Lewy bodies in a case-control study of Alzheimer's disease', International Psychogeriatrics, 21, pp. 688 - 695

Brooks D; Halliday GM, 2009, 'Intralaminar nuclei of the thalamus in Lewy body diseases', Brain Research Bulletin, 78, pp. 97 - 104

Mehta P; Mellick GD; Rowe DB; Halliday GM; Jones MM; Manwaring N; Vandebona H; Silbum P; Wang JJ; Mitchell P; Sue C, 2009, 'Mitochondrial DNA Haplogroups J and K are not Protective for Parkinson`s Disease in the Australian Community', Movement Disorders, 24, pp. 290 - 292

Sokolova A; Hill MD; Rahimi F; Warden LA; Halliday GM; Shepherd CE, 2009, 'Monocytle chemoattractant protein-1 plays a dominant role in the chronic inflammation observed in Alzheimer's disease', Brain Pathology, 19, pp. 392 - 398

Dickson D; Braak H; Duda J; Duyckaerts C; Gasser T; Halliday GM; Hardy J; Leverenz J; Del Tredici K; Wszolek Z; Litvan I, 2009, 'Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria', , 8, pp. 1150 - 1157

Halliday GM; Herrero M; Murphy K; Mccann H; Ros-Bernal F; Barcia C; Mori H; Blesa F; Obeso J, 2009, 'No Lewy pathology in monkeys with over 10 years of severe MPTP parkinsonism', Movement Disorders, 24, pp. 1519 - 1545

Mackenzie IR; Neumann M; Bigio E; Cairns NJ; Alafuzoff I; Kril J; Kovacs G; Ghetti B; Halliday GM; Holm I; Ince PG; Kamphorst W; Revesz T; Rozemuller A; Kumar-Singh S; Akiyama H; Baborie A; Spina S; Dickson DW; Trojanowski JQ; Mann DM, 2009, 'Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: Consensus recommendations', ACTA Neuropathologica, 117, pp. 15 - 18

Shepherd CE; Gregory G; Warden L; Halliday G, 2009, 'O2‐03‐02: Oligomeric Aβ40 species accumulate in the toxic plaques in Alzheimer's disease', Alzheimer's & Dementia, 5, http://dx.doi.org/10.1016/j.jalz.2009.05.335

Monoranu C; Apfelbacher M; Grunblatt E; Puppe B; Alafuzoff I; Ferrer I; Al-Saraj S; Keyvani K; Schmitt A; Falkai P; Schittenhelm J; Halliday GM; Kril J; Harper C; Mclean C; Riederer P; Roggendorf W, 2009, 'pH measurement as quality control on human post mortem brain tissue: A study of the BrainNet Europe consortium', Neuropathology and Applied Neurobiology, 35, pp. 329 - 337

Van Eersel J; Bi M; Ke Y; Hodges JR; Xuereb J; Gregory GC; Halliday GM; Gotz J; Kril J; Ittner L, 2009, 'Phosphorylation of soluble tau differs in Pick's disease and Alzheimer's disease brains', Journal of Neural Transmission, 116, pp. 1243 - 1251

Truong L; Brooks D; Amaral F; Henderson J; Halliday GM, 2009, 'Relative preservation of thalamic centromedian nucleus in Parkinsonian patients with dystonia', Movement Disorders, 24, pp. 2128 - 2135

Halliday GM, 2009, 'Thalamic changes in Parkinson's disease', Parkinsonism and Related Disorders, 15S3, pp. S152 - S155

Davies R; Halliday GM; Xuereb J; Kril J; Hodges JR, 2009, 'The neural basis of semantic memory: Evidence from semantic dementia', Neurobiology of Aging, 30, pp. 2043 - 2052

Back to profile page